Background
Attention Deficity Activity Disorder (ADHD) is a neurological disorder characterized by: impulsivity, hyperactivity, and inattention.
Patients of ADHD have an innate school and work-place disadvantage, due to loss of productivity, organization, stress management, and attention span.
ADHD Treatment market value was $6.9 Billion in 2013, and is estimated to grow to $9.9 billion by 2020, with 18 million estimated annual diagnoses.
Current solutions include: stimulants, non-stimulants, and behavioral therapy. The average treatment cost ranges between $2,000 to $15,000 annually, per person.
Patients of ADHD have an innate school and work-place disadvantage, due to loss of productivity, organization, stress management, and attention span.
ADHD Treatment market value was $6.9 Billion in 2013, and is estimated to grow to $9.9 billion by 2020, with 18 million estimated annual diagnoses.
Current solutions include: stimulants, non-stimulants, and behavioral therapy. The average treatment cost ranges between $2,000 to $15,000 annually, per person.